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7Department of Pathology, Bambino Gesu` Children’s Hospital, Rome, ItalyFatty liver disease is mainly caused by alcohol consumption, excessive body weight, dyslipidemia and impaired glucose
tolerance, but inherited disorders can sometimes be involved. We report the case of a 40-year-old woman with steatohep-
atitis and severe portal hypertension, associated with ichthyosis, cataract and hypoacusia. The clinical, pathological and
genetic ﬁndings were consistent with a diagnosis of Chanarin–Dorfman syndrome (CDS), a rare autosomal recessive inher-
ited neutral lipid storage disorder, and genetic analysis showed that a novel ABHD5 mutation is responsible.
 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
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Fatty liver disease is increasingly common in
resource-rich countries. The main causes include alcohol
consumption, overweight, and lipid and carbohydrate
metabolism disorders, but genetic diseases may some-
times also be involved.
Chanarin–Dorfman syndrome (CDS) is an autoso-
mal recessive genetic disorder of neutral lipid storage
that leads to the intracellular accumulation of triacyl
glycerols. It is characterised by a clinical phenotype
extending from isolated cutaneous manifestations (ich-0168-8278/$34.00  2008 European Association for the Study of the Liver.
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myopathy, cataracts and neurological disease), and
mutations in the ABDH5 gene (CGI58, chromosome
3p21.33) [1,2] are involved in its pathogenesis. A labora-
tory diagnosis of CDS requires the detection of lipid
vacuoles in peripheral blood neutrophils (also called
Jordan’s anomaly) [3,4], and can be conﬁrmed by
genetic testing [5,6]. Approximately 40 cases of CDS
have so far been reported in peer-reviewed medical jour-
nals. Liver enzyme abnormalities and hepatic steatosis
are common ﬁndings, but severe liver disease has only
been described in a few cases.
Herein we describe a case of severe fatty liver disease
and hepatic decompensation in a CDS patient bearing a
novel ABHD5 mutation.2. Case report
In July 2006, a 40-year-old Italian woman was admit-
ted to a primary care health facility because of varicealPublished by Elsevier B.V. All rights reserved.
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after blood transfusion, ﬂuid restoration and emergency
variceal ligation, was transferred to our hospital. She
had no history of alcohol or drug exposure, and her
family history was not signiﬁcant. She had suﬀered from
ichthyosis since childhood, and this was conﬁrmed by a
physical examination that showed erythroderma with
ﬁne scales and palmar and plantar hyperkeratosis. Her
body mass index (BMI) was 24.1 kg/m2, and she had
no ascites or other physical signs of chronic liver disease.
Table 1 summarises the results of routine laboratory
tests. Her aminotransferase values were slightly
increased, but her platelet count, bilirubin level and liver
synthesis tests were normal. Hepatitis B and C serology
was negative. An abdominal ultrasound examination
revealed a small liver that was free of focal lesions but
with surface nodularity which, in our setting, is a speciﬁc
sign of cirrhosis [7]. Portal hypertension was conﬁrmed
by the dilatation of the portal vein with hepatofugal
ﬂow, and severe splenomegaly (longitudinal diameter
16 cm).
Second-line laboratory assessments showed the pres-
ence of a low antinuclear antibody (ANA) titre of 1:160
with a speckled pattern, but no other sign of autoimmu-
nity (no evidence of anti-mitochondria, anti-smooth
muscle, or liver or kidney microsome antibodies) or
anti-transglutaminase antibodies were negative. HerTable 1
Laboratory tests at hospital admission
Test Normal
value
Patient’s
value
Haemoglobin 12–16 g/dl 4.1
MCV 80–97 ﬂ 78
Platelet count 150.000–400.000 mm3 155.000
Aspartate
aminotransferase (AST)
0–33 U/l 45
Alanino
aminotransferase (ALT)
0–31 U/l 37
Gamma
glutamyltransferase (GGT)
0–32 U/l 32
Bilirubin <1.2 mg/dl 1.0
Albumin 3.4–4.8 g/dl 3.51
PT ratio 0.80–1.22 1.16
Cholesterol 100–190 mg/dl 168
Glicosilated haemoglobin <4.5 % <4.5%
Immunoglobulin G (IgG) 9–18 % 20.5%
Ferritin 10–100 ng/ml 41
Alpha fetoprotein <7 ng/ml 3.3
HBsAg Negative Negative
Anti-HCV antibody Negative Negative
Antinuclear
antibody (ANA)
Negative 1:160
specked
Anti-smooth muscle (ASMA) Negative Negative
Ab anti-mitochondria (AMA) Negative Negative
Liver or kidney
microsome antibodies (LKM)
Negative Negative
Alpha 1 antitrypsin Negative Negative
Ceruloplasmin Negative Negativeceruloplasmin, alpha 1-antitrypsin, serum ferritin and
tranferrin saturation levels were normal.
Histological examination of a percutaneous liver
biopsy sample obtained using an 18 gauge needle docu-
mented the presence of diﬀuse macro and microvesicular
steatosis with a subverted architecture and ﬁbrosis
(Fig. 1).
Given the absence of common risk factors for fatty
liver disease and the severity of the patient’s clinical pic-
ture, we suspected a complex disease or a rare syndrome.
The presence of ichthyosis reminded us of a case report
that had appeared in the medical literature a few days
earlier [1]; this case had a number of analogies with
our own and led us to consider the hypothesis of a lipid
storage disorder, particularly CDS. To test this hypoth-
esis, we interviewed the patient further, and carried out
some additional laboratory analyses. The patient admit-
ted to having suﬀered from mild neurosensorial deafness
since childhood, and having been diagnosed with bilat-
eral cataracts a few years earlier, and we conﬁrmed these
impairments by means of audiometric tests and ophthal-
mological assessment. In addition, a peripheral blood
smear showed Jordan’s anomaly (i.e. the presence of
lipid vacuoles in peripheral neutrophils), which is
regarded as the hallmark of neutral lipid storage disease
syndromes (Fig. 2) [3,8]. The patient was therefore dis-
charged from hospital in a stable condition with a clin-
ical diagnosis of CDS, and included an outpatient
follow-up programme. Prophylactic therapy with the
beta-blocker nadolol at a dose of 80 mg per day, was
prescribed.
The diagnosis of CDS was subsequently conﬁrmed
by ABHD5 sequencing, which showed a previously
unreported homozygous splice-site mutation in intron
1 leading to the alternative splicing of intron 1 pre-
mRNA, the retention of intron 1 itself within the
mature RNA, and the production of an abnormal
protein. Furthermore, the histology was reviewed at
a tertiary reference liver pathology centre for meta-
bolic disorders, which formulated a diagnosis of
‘‘non-alcoholic steatohepatitis” with ‘‘the presence of
macrovacuolar steatosis, ballooning hepatocytes, Mal-
lory bodies, inﬂammatory inﬁltrate, and pericellular
ﬁbrosis, compatible with CDS”.
In February 2007, the patient experienced a second
episode of variceal hemorrhaging, which was treated
by endoscopic variceal ligation and the placement of a
transjugular intrahepatic portal systemic shunt (TIPPS).
The patient’s clinical condition progressively deterio-
rated due to the presence of portosystemic encephalop-
athy, a decreasing platelet count (81,000 mm3),
increasing bilirubin levels (3.47 mg/dl), and reduced
hepatic synthesis (albumin 2.98 g/dl). Her Child-Pugh
score was B8, and MELD score 13. She is currently
(January 2008) on the waiting list for liver
transplantation.
Fig. 1. E.E. 100 (a), 250 (b). Liver histology documented the
presence of diﬀuse macro and microvesicular steatosis with a mildly
subverted architecture and ﬁbrosis, inﬂammatory inﬁltrate, ballooning
hepatocytes with glycogenate nuclei, and Mallory bodies. [This ﬁgure
appears in colour on the web.]
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Our patient presented severe portal hypertension and
histological evidence of severe steatohepatitis, but was
not aﬀected by viral hepatitis and had no common risk
factors for alcoholic or non-alcoholic fatty liver disease.
This unusual presentation, together with the concomi-Fig. 2. Microphotographs of May-Gru¨nwald-Giemsa (A) and Nile red (NR)
ﬂuorescent image has been merged with the corresponding DAPI image). Mag
laboratory ﬁnding in CDS patients, is the presence of lipid vacuoles in peripheral
consist of triacyl glycerols or cholesterol esters surrounded by a monolayer oftant presence of a relatively uncommon congenital der-
matological manifestation (ichthyosis), guided us
towards the diagnosis of CDS, a rare multisystemic dis-
ease. Jordan’s anomaly (the distinctive laboratory ﬁnd-
ing for neutral lipid storage disorders) was detected in
granulocytes by means of the routine May-Gru¨nwald-
Giemsa staining of a blood smear. Routine microscopic
examination showed that the droplets were morpholog-
ically very similar to those observed in steatotic hepato-
cytes. As May-Gru¨nwald-Giemsa-negative spots may
also be due to cell inclusions not containing neutral lip-
ids or staining artefacts, we used a newly described
immunohistochemistry method to conﬁrm the droplets’
composition [8]. Genetic analysis conﬁrmed that the
patient was aﬀected by an inherited disorder involving
the ABHD5 gene. We detected a point mutation of the
invariant G of the GT intron 1 donor splice-site giving
rise to the truncation of the ABDH5 open reading frame
by a premature stop codon, which results in an abnor-
mal protein that is expected to be non-functional as it
lacks approximately 96% of amino acid residues.
Approximately 40 patients of CDS have so far been
described, only some of whom have undergone genetic
testing to identify speciﬁc ABHD5 gene mutations
[5,6]. We reviewed the original cases of CDS published
in peer-reviewed journals [9–16], and found that liver
involvement is the second most common clinical
manifestation after ichthyosis, with abnormal liver
enzyme levels being documented in about 78% of
the patients. However, end-stage liver disease has so
far been described in only six cases (15%) including
our own. Interestingly, most of the patients suﬀering
from hepatic decompensation were more than 40 years
old at the time of diagnosis, as compared to a mean
age of 19 years among those with little or no hepatic
involvement, which suggests that a longer disease
duration may favour the onset of hepatic complica-
tions. However, as the mutation identiﬁed in our
patient has never been described before, we cannot
exclude the possibility that the severity of her clinical
picture was inﬂuenced by the type of genetic defect
involved.and DAPI-stained (B) buﬀy coats showing Jordan’s anomaly (the NR
niﬁcation: 100. Scale bar: 10 lm. Jordan’s anomaly, the most common
leukocytes (neutrophils and eosinophils neutrophils). They predominantly
phospholipids and proteins. [This ﬁgure appears in colour on the web.]
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always the consequence of unhealthy dietary and drink-
ing habits, but can sometimes be caused by rare genetic
syndromes. In addition to neutral lipid storage diseases,
other inherited disorders manifesting as severe fatty
inﬁltration of the liver include congenital mitochondri-
opathies, hypobetalipoproteinemia, choline deﬁciency,
and ornithine transcarbamylase and carnitine palmitoyl
transferase deﬁciencies [1]. Although their frequency is
not comparable with that of acquired metabolic fatty
liver diseases, their potentially aggressive clinical course
means they should not be forgotten.
Finally, our experience highlights the importance of
serendipitous events in the diagnosis of rare conditions.
Electronic databases can support the insuﬃcient capac-
ity of human minds to retain information, and searching
for symptom associations may be helpful but, in the
present case, only our regular reading of a medical jour-
nal reporting clinical cases allowed us to reach a diagno-
sis. Case reports may therefore be a direct diagnostic,
and are essential for deﬁning the clinical spectrum of
rare diseases.
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